Browse recruiting and upcoming clinical trials for X-linked hypophosphatemia.
Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026
About this listHide
ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.
Who can join AIAdults with confirmed rare bone or cartilage disorders (e.g., osteogenesis imperfecta, X-linked hypophosphatemia, mucopolysaccharidoses) or healthy adult dental controls.
What is being studied AI3D intra-oral scans and shape analysis to train AI classifiers for rare bone disorder syndromes.
Who can join AIChildren and adolescents (ages 2–18) with X‑linked hypophosphataemia (XLH) who have received paediatric Burosumab treatment for at least 12 months.
What is being studied AIWhether lower starting burosumab doses achieve biochemical control of serum phosphate in children with XLH.